Fanni Gergely elected to EMBO Membership
Dr Fanni Gergely, Senior Group Leader at the Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research.
Fanni is one of 56 new members who are joiningĀ more than 1800 of the best researchers in Europe and around the world.
Election to EMBO Membership is recognition of research excellence and the outstanding achievements made by a life scientist.Ā EMBO Members actively participate in the execution of the organisationās initiatives by serving on Council, committees and editorial boards, and by evaluating applications for EMBO funding.Ā As a result, EMBO Members collectively influence the future directions of life science research and strengthen research communities across Europe.
It is an honour to be elected a member of EMBO.Ā This award also recognises the research efforts of my talented team and fantastic collaborators
Dr Fanni Gergely, Cancer Research UK Cambridge Institute
Fanniās researchĀ seeks to understand how centrosomes contribute to normal and pathological processes such as embryonic growth, neurodevelopment and tumourigenesis. By using a combination of genetic, molecular and proteomic tools, her team interrogates the roles of centrosome components in cell proliferation and signalling. Most recently, the groupās work is focused on identifying tissue-specific functions for these ubiquitous organelles.
āIt is an honour to be elected a member of EMBO by my peers.Ā This award also recognises the research efforts of my talented team and fantastic collaborators, all made possible by the invaluable support of Cancer Research UK and the Cambridge Instituteā says Fanni. āI look forward to contributing to EMBOās valuable work strengthening the research community in Europe and beyond.ā
EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines
Maria Leptin, EMBO Director
āEMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,ā says EMBO Director Maria Leptin.
The new EMBO Members and Associate Members will be formally welcomed at the annual Membersā Meeting in Heidelberg between 29 and 31 October 2019.
Read more
Cambridge scientists recognised by major European research organisation
Related News
See all news-
Dr Richard Mair to co-lead £13.7M investment for brain tumour research
19th December 2025
The National Institute for Health and Care Research (NIHR) has today announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
Find out more -
Order of cancer-driving mutations affects the chance of tumour developmentĀ
3rd December 2025
New research from the Winton Group has revealed that the order of cancer-driving mutations plays an important role in whether tumours in the intestine can develop.
Find out more -
Cancer Detectives: New Channel 4 Documentary Showcases Cambridge Brain Cancer Trial
27th November 2025
A Cambridge researcher offering new hope to people with brain tumours is the focus of a documentary exploring the science behind the next big breakthroughs.
Find out more